MicroRNA in cancer prognosis.
作者信息
Slack Frank J, Weidhaas Joanne B
出版信息
N Engl J Med. 2008 Dec 18;359(25):2720-2. doi: 10.1056/NEJMe0808667.
Abstract
摘要
相似文献
1
MicroRNA in cancer prognosis.癌症预后中的微小RNA
N Engl J Med. 2008 Dec 18;359(25):2720-2. doi: 10.1056/NEJMe0808667.
2
Dicer and outcomes in patients with acute myeloid leukemia (AML).急性髓系白血病（AML）患者中的Dicer与预后
Leuk Res. 2009 Aug;33(8):e127. doi: 10.1016/j.leukres.2009.02.003. Epub 2009 Mar 10.
3
Dicer, Drosha, and outcomes in patients with ovarian cancer.Dicer、Drosha与卵巢癌患者的预后
N Engl J Med. 2008 Dec 18;359(25):2641-50. doi: 10.1056/NEJMoa0803785.
4
Dicer and Drosha in ovarian cancer.卵巢癌中的Dicer和Drosha
N Engl J Med. 2009 Mar 12;360(11):1150-1; author reply 1151. doi: 10.1056/NEJMc090085.
5
Down-regulation of dicer expression in ovarian cancer tissues.卵巢癌组织中 dicer 表达下调。
Clin Biochem. 2010 Feb;43(3):324-7. doi: 10.1016/j.clinbiochem.2009.09.014. Epub 2009 Sep 25.
6
Hypoxia: micro changes.缺氧：微观变化。
Nat Rev Cancer. 2014 Jun;14(6):382-3. doi: 10.1038/nrc3754. Epub 2014 May 15.
7
Dicer cuts the kidney.Dicer切割肾脏。
J Am Soc Nephrol. 2008 Nov;19(11):2043-6. doi: 10.1681/ASN.2008090986. Epub 2008 Oct 15.
8
Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma.Argonaute、Dicer 和 Drosha 在浆液性卵巢癌的肿瘤进展过程中上调。
Hum Pathol. 2012 Nov;43(11):2062-9. doi: 10.1016/j.humpath.2012.02.016. Epub 2012 May 29.
9
Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P.自噬降解 SQSTM1 通过降低 DICER1 和 AGO2 诱导 MIRLET7A-3P，从而抑制卵巢癌细胞的迁移。
Autophagy. 2018;14(12):2065-2082. doi: 10.1080/15548627.2018.1501135. Epub 2018 Aug 17.
10
miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1.miR-98-5p 通过靶向 Dicer1 抑制 miR-152 的生成从而促进上皮性卵巢癌对顺铂的耐药性。
Cell Death Dis. 2018 May 1;9(5):447. doi: 10.1038/s41419-018-0390-7.
引用本文的文献
1
A bioswitchable delivery system for microRNA therapeutics based on a tetrahedral DNA nanostructure.一种基于四面体DNA纳米结构的用于微小RNA治疗的生物可切换递送系统。
Nat Protoc. 2025 Feb;20(2):336-362. doi: 10.1038/s41596-024-01050-7. Epub 2024 Aug 30.
2
Using microRNAs Networks to Understand Pancreatic Cancer-A Literature Review.利用微小RNA网络理解胰腺癌——文献综述
Biomedicines. 2024 Aug 1;12(8):1713. doi: 10.3390/biomedicines12081713.
3
Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development.miRNA-21 对心脏纤维化发展相关通路和机制的抑制作用。
Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447241253134. doi: 10.1177/17539447241253134.
4
MicroRNAs as Potential Biomarkers in Gynecological Cancers.微小RNA作为妇科癌症的潜在生物标志物
Biomedicines. 2023 Jun 13;11(6):1704. doi: 10.3390/biomedicines11061704.
5
Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy.针对脑瘤治疗的靶向多个癌基因 miRNA 的反义 PNAs。
Sci Adv. 2023 Feb 10;9(6):eabq7459. doi: 10.1126/sciadv.abq7459. Epub 2023 Feb 8.
6
microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells.microRNA-21 调控胰腺导管腺癌细胞的干性。
Int J Mol Sci. 2022 Jan 24;23(3):1275. doi: 10.3390/ijms23031275.
7
MicroRNA-106a suppresses prostate cancer proliferation, migration and invasion by targeting tumor-derived IL-8.微小RNA-106a通过靶向肿瘤源性白细胞介素-8抑制前列腺癌的增殖、迁移和侵袭。
Transl Cancer Res. 2020 May;9(5):3507-3517. doi: 10.21037/tcr.2020.03.70.
8
MicroRNA-133b expression inversely correlates with MET and can serve as an optimum predictive biomarker for patients of colorectal cancer.微小RNA-133b的表达与间质-上皮转化因子（MET）呈负相关，可作为结直肠癌患者的最佳预测生物标志物。
Transl Cancer Res. 2021 Jan;10(1):57-64. doi: 10.21037/tcr-20-2370.
9
Methylation of and as a Biomarker for the Detection of Lung Cancer.作为肺癌检测生物标志物的[具体甲基化对象]甲基化
Cancers (Basel). 2021 Dec 6;13(23):6139. doi: 10.3390/cancers13236139.
10
Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy.胰腺导管腺癌中的非编码RNA：改善诊断和治疗的新方法
Transl Oncol. 2021 Jul;14(7):101090. doi: 10.1016/j.tranon.2021.101090. Epub 2021 Apr 5.
本文引用的文献
1
Dicer, Drosha, and outcomes in patients with ovarian cancer.Dicer、Drosha与卵巢癌患者的预后
N Engl J Med. 2008 Dec 18;359(25):2641-50. doi: 10.1056/NEJMoa0803785.
2
Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer.血清和组织生物标志物作为上皮性卵巢癌的预测和预后变量
Crit Rev Oncol Hematol. 2009 Jan;69(1):12-27. doi: 10.1016/j.critrevonc.2008.05.001. Epub 2008 Jul 1.
3
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.肿瘤细胞减灭术后的肿瘤残留对IV期上皮性卵巢癌临床结局的预测：一项妇科肿瘤学组研究
J Clin Oncol. 2008 Jan 1;26(1):83-9. doi: 10.1200/JCO.2007.13.1953. Epub 2007 Nov 19.
4
Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma.晚期IIIC期卵巢癌初次手术后生存情况的列线图
Gynecol Oncol. 2008 Jan;108(1):191-4. doi: 10.1016/j.ygyno.2007.09.020. Epub 2007 Oct 24.
5
Impaired microRNA processing enhances cellular transformation and tumorigenesis.微小RNA加工受损会增强细胞转化和肿瘤发生。
Nat Genet. 2007 May;39(5):673-7. doi: 10.1038/ng2003. Epub 2007 Apr 1.
6
Oncomirs - microRNAs with a role in cancer.癌基因miRNA——在癌症中发挥作用的微小RNA。
Nat Rev Cancer. 2006 Apr;6(4):259-69. doi: 10.1038/nrc1840.
7
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.肺癌诊断和预后中的独特微小RNA分子谱。
Cancer Cell. 2006 Mar;9(3):189-98. doi: 10.1016/j.ccr.2006.01.025.
8
A microRNA expression signature of human solid tumors defines cancer gene targets.人类实体瘤的微小RNA表达特征可确定癌症基因靶点。
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61. doi: 10.1073/pnas.0510565103. Epub 2006 Feb 3.
9
Combinatorial microRNA target predictions.组合式微小RNA靶标预测
Nat Genet. 2005 May;37(5):495-500. doi: 10.1038/ng1536. Epub 2005 Apr 3.
10
Reduced expression of Dicer associated with poor prognosis in lung cancer patients.Dicer表达降低与肺癌患者的不良预后相关。
Cancer Sci. 2005 Feb;96(2):111-5. doi: 10.1111/j.1349-7006.2005.00015.x.
Zotero 插件